bioAffinity advances CyPath Lung test for lung cancer survivor surveillance
bioAffinity Technologies said it is advancing the potential application of its CyPath Lung test for surveillance of lung cancer survivors.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.